The economics of clinical trial patient recruitment are not complicated. Paid digital advertising — Facebook, Google, programmatic display, and health-targeted media — generates patients at a cost of $1,500 to $5,000 per enrolled patient depending on the therapeutic area and protocol complexity. Physician referral generates patients at a cost of $200 to $800 per enrolled patient. That is a 3 to 10 times cost difference on the most important operational metric in clinical research.
The reason most sites default to paid media despite the cost disadvantage is that paid media scales faster and requires less operational infrastructure. Run the ads, build a landing page, collect inquiries. Physician referral requires identifying physicians, building outreach sequences, maintaining relationships, and having a system for pre-screening referrals that arrives. Sites without that system cannot run physician referral at scale, so they use paid media. The infrastructure cost is real — but so is the cost of the alternative.
Why Physician-Referred Patients Cost Less Per Enrollment
The cost difference between paid media and physician referral is primarily a function of screen failure. Paid media generates inquiries from patients who saw an ad, thought they might qualify, and filled out a form. The inquiry pool contains a large proportion of patients who do not meet eligibility criteria — the screen failure rate for paid media-generated patients typically ranges from 50 to 80 percent depending on the indication.
Physician-referred patients arrive with a layer of clinical pre-screening already applied. The referring physician knows the patient's history, knows the indication, and has applied medical judgment to the eligibility question before making the referral. Screen failure rates for physician-referred patients are significantly lower — often 20 to 40 percent — which means a higher proportion of physician-referred inquiries convert to enrolled patients. Lower screen failure means fewer visits consumed by ineligible patients, which means lower cost per enrolled patient even if the per-inquiry cost is similar.
What Each Channel Actually Costs in Practice
A realistic paid media budget for a clinical trial site running a Phase III trial in a competitive indication is $8,000 to $15,000 per month in advertising spend, generating 30 to 80 inquiries monthly, of which 5 to 15 percent convert to enrolled patients after screening. That produces 2 to 12 enrolled patients per month at a cost of $800 to $5,000 per enrollment.
A physician outreach program reaching 300 physicians with a 4-email sequence, plus postcard follow-up, costs approximately $1,500 to $3,000 in platform and materials costs per study. If that outreach generates a 3 percent referral rate — meaning 9 physicians each refer one patient — and 60 percent of those patients enroll after screening, the result is 5 to 6 enrolled patients at a cost of $250 to $500 per enrolled patient.
The Retention Advantage
Cost per enrolled patient is not the only economic variable. Retention — whether enrolled patients complete the protocol — has a direct financial impact on study outcome quality and per-patient revenue. Physician-referred patients who have a continuing relationship with their referring doctor are more likely to complete the study, because the physician is invested in the patient's participation and can address drop-out motivation during routine visits.
Studies with high retention rates require fewer enrolled patients to reach statistical power, which reduces total recruitment cost. Studies with high drop-out rates require larger enrollment to compensate, which drives up per-enrolled-patient costs and extends timelines. Retention is a downstream effect of the recruitment channel — and physician referral's advantage in this area is consistent across therapeutic areas.
The Infrastructure Question
The argument for physician referral over paid media is not that paid media has no value. Both channels serve purposes, and most sites running at capacity use both. The argument is that physician referral produces structurally better economics per enrolled patient, and that the infrastructure required to scale it — systematic physician identification, automated outreach sequences, referral intake management — is a one-time build that improves in efficiency with each study that runs through it.